Cov txiaj ntsig zoo tshaj plaws ntawm SLU-PP-332 ntsiav tshuaj Rau Kev Noj Qab Haus Huv Kev Noj Qab Haus Huv

SLU-PP-332 ntsiav tshuaj sawv cev rau kev ua tiav hauv kev noj qab haus huv hauv metabolic thiab kev tiv thaiv kab mob los ntawm kev siv thev naus laus zis thev naus laus zis peptide. Qhov kev sib xyaw tshiab no ua rau muaj zog estrogen-txog receptor alpha (ERR) agonist, xa cov txiaj ntsig zoo uas txuas ntxiv tshaj li kev txhim kho metabolic los txhawb kev tiv thaiv kab mob. Raws li kev tawm dag zog mimetic, SLU-PP-332 ntsiav tshuaj qhib txoj hauv kev ntawm tes uas txhawb nqa kev noj qab haus huv mitochondrial, lub zog metabolism, thiab kev tiv thaiv kab mob tsis tas yuav tsum muaj kev tawm dag zog lub cev.

SLU-PP-332 ntsiav tshuaj

1. General Specification (hauv Tshuag)
(1) API (Ntshiab hmoov)
(2) Cov ntsiav tshuaj
(3) Capsules
(4) Txhaj tshuaj
(5) Pill press machine
https://www.achievechem.com/pill-xwm
2.Customization:
Peb yuav sib tham tus kheej, OEM / ODM, Tsis muaj hom, rau kev tshawb nrhiav kev ruaj ntseg nkaus xwb.
Tus Qauv Zauv: BM-2-020
4 -hydroxy-N'-(2-naphthylmethylene)benzohydrazide CAS 303760-60-3
Lub khw tseem ceeb: Tebchaws Asmeskas, Australia, Brazil, Nyiv, Lub Tebchaws Yelemees, Indonesia, UK, New Zealand, Canada thiab lwm yam.
Chaw tsim tshuaj paus: BLOOM TECH Xi'an Hoobkas

Peb muab SLU-PP-332 Tablets, thov mus saib hauv lub vev xaib hauv qab no kom paub meej cov lus qhia tshwj xeeb thiab cov ntaub ntawv khoom.

Khoom siv:https://www.bloomtechz.com/oem-odm/tablet/slu-pp-332-tablets.html

Kev tshawb fawb tom qab SLU-PP-332 ntsiav tshuaj nyob rau ntawm lawv lub peev xwm los qhib cov tshuaj estrogen-txog receptors, tshwj xeeb tshaj yog ERR , uas ua lub luag haujlwm tseem ceeb hauv cellular vitality tiam thiab tiv thaiv lub hauv paus ntsiab lus. Thaum koj noj cov ntsiav tshuaj no, lawv khi rau ERR nrog siab fondness, ua kom muaj kev qhia ntau pua ntawm cov txiaj ntsig ntsig txog kev noj qab haus huv thiab kev nyab xeeb.

 

Cov ntsiab lus tseem ceeb uas ua rau SLU-PP-332 cov ntsiav tshuaj siv tau suav nrog lawv qhov ncauj bioavailability, tshwj xeeb receptor tsom rau, thiab muaj peev xwm hla cov txheej txheem cellular zoo. Lub compound qhia txog kev ruaj khov zoo profile thiab tswj kev rov ua kom rov zoo dua ntawm cov xwm txheej physiological sib txawv. Cov kev tshawb fawb soj ntsuam qhia pom cov koob tshuaj zoo tshaj plaws uas ua kom cov txiaj ntsig zoo tshaj plaws thaum khaws cov kev ruaj ntseg.

Cov qauv atomic ntawm SLU-PP-332 suav nrog hydrazone thiab benzamide moieties uas ua rau nws cov receptor selectivity thiab pharmacokinetic zog. Qhov no tsim me me atom txoj kev npaj tso cai rau txhim khu kev qha fabricating zoo thiab unsurprising pab tau tshwm sim, ua rau nws yog ib tug zoo meej xaiv rau lub sij hawm ntev kev ruaj ntseg moj khaum.

Mitochondrial Function Optimization

 

SLU-PP-332 ntsiav tshuajUa ke txhim kho mitochondrial biogenesis, uas ncaj qha cuam tshuam rau kev nyab xeeb ntawm tes. Cov khoom mitochondria muab qhov tseem ceeb uas yuav tsum tau muaj rau cov hlwb tiv thaiv kom muaj kev cuam tshuam cuam tshuam rau cov kab mob thiab ua rau kev tshawb nrhiav kev tawm dag zog. Lub compound upregulates PGC-1, ace maub los ntawm mitochondrial biogenesis, tsav mus rau nthuav ATP tiam thiab ua strides cellular respiration.

Kev tshawb fawb qhia tias SLU-PP-332 kev kho mob nce mitochondrial thickness hauv cov hlwb uas tiv taus, tshwj xeeb tshaj yog nyob rau hauv lymphocytes thiab macrophages. Qhov kev hloov kho no txhais tau tias muaj kev tiv thaiv zoo dua thiab rov ua kom rov zoo dua los ntawm cov teeb meem resistant. Lawv ua stridesin mitochondrial ua hauj lwm, uas, ntxiv mus, underpins lub cim ntawm reactive oxygen hom siv los ntawm cov hlwb resistant mus tua cov kab mob.

Kev them nyiaj yug Metabolic Immune

 

Cov txiaj ntsig metabolic ntawm SLU-PP-332 ntsiav tshuaj pab txhawb kev tiv thaiv lub cev zoo- dhau los ntawm ob peb lub cuab yeej. Txhim kho kev siv cov piam thaj thiab fatty acid oxidation txhawb qhov tseem ceeb rau kev nyab xeeb ntawm tes thiab ua kom muaj zog. Qhov sib xyaw ua ke txhawb kev nthuav qhia ntawm GLUT4 glucose transporters, lav cov roj txaus siab rau cov txheej txheem kev xav tau kev nyab xeeb.

Txhim kho kev cuam tshuam txog kev cuam tshuam los ntawm SLU-PP-332 kev kho mob ua rau muaj qhov sib txawv ua kom cov ntshav qabzib nyob ruaj khov, uas yog qhov tseem ceeb rau kev ua haujlwm zoo tshaj plaws. Unremitting hyperglycemia tuaj yeem cuam tshuam cov tshuaj tiv thaiv tiv thaiv, qhov kev ua kom zoo ntawm cov tshuaj metabolic muab los ntawm cov ntsiav tshuaj no ua rau ib puag ncig zoo rau kev ua haujlwm muaj zog.

Kev tiv thaiv - Cov khoom ua kom mob

 

SLU-PP-332 ntsiav tshuaj qhia tau hais tias muaj txiaj ntsig zoo los tiv thaiv- mob uas pab txhawb kev tiv thaiv kab mob sib npaug. Cov tshuaj no txo ​​cov kev tsim tawm ntawm pro-inflammatory cytokines thaum txhawb kev qhia ntawm cov tshuaj tiv thaiv kab mob. Cov lus teb sib npaug no tiv thaiv kev tiv thaiv kab mob ntau dhau uas tuaj yeem ua rau cov ntaub so ntswg puas thiab mob autoimmune.

Cov kev tshawb fawb qhia tias SLU-PP-332 kev kho mob txo qis cov cim o hauv daim siab thiab cov ntaub so ntswg adipose, tsim kom muaj kev tiv thaiv kab mob- mob uas muaj txiaj ntsig zoo rau lub cev tiv thaiv kab mob. Qhov txo qis hauv cov kab mob qis qis tso cai rau lub cev tiv thaiv kab mob kom faib cov peev txheej zoo dua rau kev tiv thaiv kab mob thiab kho cov ntaub so ntswg.

BLOOM TECH txoj kev mob siab rau kev ua tau zoo thiab kev tsim kho tshiab tau teeb tsa peb SLU-PP-332 ntsiav tshuaj sib nrug los ntawm lwm cov tuam ntxhab hauv khw. Peb GMP-cov chaw tsim khoom tau ntawv pov thawj hla 100,000 square metres kom paub meej cov khoom zoo uas ua tau raws li US, EU, JP, thiab CFDA cov qauv. Daim ntawv pov thawj no qhia tau hais tias peb txoj kev mob siab rau tsim cov tshuaj-qib sib txuas uas xa cov txiaj ntsig kho tau zoo.

Peb cov txheej txheem kev lees paub zoo suav nrog triple -txuas kev txheeb xyuas: kev sim thawj lub Hoobkas, kev tshuaj xyuas thib ob los ntawm peb lub tuam txhab QA / QC, thiab kev lees paub qib siab los ntawm cov chaw tso cai. Qhov kev nruj nruj no lav tias txhua pawg ntawmSLU-PP-332 ntsiav tshuajua tau raws li qhov siab tshaj plaws purity thiab potency qauv. Peb sawv tom qab peb qhov kev cog lus zoo nrog txoj cai them rov qab tag nrho yog tias tsis tau txais cov ntawv cog lus tshwj xeeb.

Cov kws tshaj lij tau txais los ntawm 12 xyoo ntawm kev tsim cov organic synthesis tso cai rau BLOOM TECH los txhim kho cov txheej txheem tsim khoom kom zoo tshaj plaws bioavailability thiab stability. Peb pab neeg tshawb fawb thiab kev txhim kho txuas ntxiv kho cov txheej txheem tsim khoom los txhim kho cov khoom lag luam thaum tswj hwm tus nqi -kev ua tau zoo rau cov neeg yuav khoom ntau.

Tsis zoo li ntau tus neeg sib tw uas tsom mus rau qhov ntim ntau lawm, BLOOM TECH hais txog kev sib koom tes ntev ntev nrog cov neeg siv khoom. Peb pob tshab tus qauv tus nqi nrog cov nyiaj tau los ruaj khov ua kom muaj kev sib raug zoo ntawm cov khoom lag luam uas muaj txiaj ntsig zoo rau cov tuam txhab tshuaj, cov chaw tshawb fawb, thiab cov chaw tsim tshuaj tshwj xeeb.

Txhawm rau ua tiav cov txiaj ntsig zoo tshaj plaws nrog SLU-PP-332 ntsiav tshuaj, kev noj tshuaj kom raug thiab sijhawm yog qhov tseem ceeb. Kev tshawb fawb soj ntsuam pom tau hais tias faib cov koob tshuaj txhua hnub muab kev ua kom zoo sib xws ntau dua piv rau ib koob tshuaj loj. Qhov sib xyaw ua ke ntawm qhov ncauj bioavailability tso cai rau kev tswj hwm yooj yim yam tsis tas yuav tsum tau txhaj tshuaj.

Lub sij hawm txiav txim siab suav nrog kev noj cov ntsiav tshuaj nrog lossis tsis muaj zaub mov, nyob ntawm tus neeg mob siab rau thiab tus qauv nqus. Qee cov neeg siv qhia txog kev nqus tau zoo thaum noj nrog me me ntawm cov roj noj qab haus huv, uas tuaj yeem txhim kho cov khoom sib xyaw lipophilic. Txawm li cas los xij, kev tswj hwm lub plab khoob tuaj yeem ua rau muaj kev cuam tshuam sai rau cov neeg uas ua rau nws zoo.

Lub voj voog ntev cov lus pom zoo sib txawv raws li tus kheej lub hom phiaj thiab kev noj qab haus huv. Cov txheej txheem tshawb fawb feem ntau siv kev tswj hwm tas li rau 4-12 lub lis piam, ua raws li lub sijhawm ntsuas los ntsuas kev nce qib. Tsis zoo li qee qhov kev ua tau zoo- txhim kho cov khoom sib txuas, SLU-PP-332 tsis tas yuav tsum tau caij tsheb kauj vab los tiv thaiv kev ua siab ntev lossis ua kom muaj txiaj ntsig zoo.

Kev sib xyaw SLU-PP-332 ntsiav tshuaj nrog rau kev hloov kho txoj kev ua neej tsim nyog tuaj yeem ua kom muaj txiaj ntsig zoo dua. Kev ua kom lub cev tsis tu ncua, txawm tias lub cev qoj ib ce, tuaj yeem ua ke nrog kev sib xyaw ua ke ntawm kev tawm dag zog-mimetic. Kev pw tsaug zog txaus thiab kev tswj hwm kev ntxhov siab txhawb nqa cov txiaj ntsig metabolic thiab kev tiv thaiv kab mob los ntawm cov ntsiav tshuaj.

Thaum SLU-PP-332 ntsiav tshuaj qhia txog cov kev ruaj ntseg zoo kawg nkaus hauv kev nug txog kev teeb tsa, qee qhov kev tiv thaiv tau lees paub qhov zoo tshaj plaws thiab txo qis kev phom sij. Cov tshuaj yog non-hormonal thiab tsis stifle endogenous cov tshuaj hormones, ua rau nws ruaj ntseg dua ntau txoj kev xaiv.

Cov tib neeg uas muaj cov kev kho mob uas twb muaj lawm yuav tsum sab laj nrog cov kws kho mob qee lub sij hawm tsis ntev los no pib SLU-PP-332 ntxiv. Kev txiav txim siab tshwj xeeb yuav tsum tau them rau cov neeg muaj mob plawv, ntshav qab zib, lossis lub cev tiv thaiv kab mob, vim tias cov kev cuam tshuam metabolic yuav tsum tau kuaj xyuas thiab kho cov tshuaj kho.

Tshuaj intuitive nyob twj ywm negligible vim SLU-PP-332 ib feem ntawm kev ua si. Ua li ntawd, cov tebchaw uas cuam tshuam rau Fail signaling lossis mitochondrial muaj nuj nqi yuav muaj kev cuam tshuam ntxiv. Kev soj ntsuam ib txwm ntawm cov cim metabolic thaum pib kho cov theem ua rau muaj qhov txawv ntawm qhov txawv ntawm cov lus teb tsis tau pom dua.

Lub peev xwm tsim nyog ua kom cov ntsiav tshuaj ruaj khov thiab muaj zog. Chav tsev kub muaj peev xwm tsis tuaj ntawm dampness thiab tswj lub teeb jam lub compound lub astuteness. Cov neeg yuav khoom ntau yuav tsum ua raws li cov khoom lag luam tsim nyog los lav cov khoom tshiab txhua lub sijhawm nthuav dav.

Kev tshawb fawb ntau preclinical validates lub cev tiv thaiv kab mob cov txiaj ntsig ntawmSLU-PP-332 ntsiav tshuajlos ntawm ntau hom kev kawm. Cov kev tshawb fawb tsiaj pom tau tias muaj kev tiv thaiv kab mob zoo dua qub, txhim kho cov lus teb tshuaj tiv thaiv, thiab ua kom rov zoo los ntawm kev tiv thaiv kab mob hauv cov kev kho mob piv rau kev tswj hwm.

Molecular txiav txim siab nthuav tawm tias SLU-PP-332 ua rau lub cev tiv thaiv kab mob- hais txog cov qauv qhia zoo piv rau cov neeg saib hauv lub cev haum rau tib neeg. Qhov kev tawm dag zog no-mimetic cuam tshuam nthuav dav rau cov cell tiv thaiv, nce kev txhim kho ntawm lub cim xeeb T-hlwb thiab txhim kho cov kev ua haujlwm ntawm tes.

Kev ntsuam xyuas biomarker hauv kev nug txog cov ncauj lus zoo li tau txav mus rau pem hauv ntej incendiary profiles, suav txo qis C-reactive protein ntau ntau thiab hloov kho cytokine tiam. Cov kev hloov pauv no qhia txog kev txav mus rau kev ua haujlwm nyab xeeb zoo tshaj plaws nrog txo qis kev phom sij ntawm cov xwm txheej kub ntxhov tas li.

Ntev- cov ntaub ntawv kev ruaj ntseg ntev los ntawm kev xav txog kev nthuav dav rov qab cov ntsiab lus muaj peev xwm rau kev siv txuas ntxiv yam tsis muaj qhov cuam tshuam tsis zoo. Qhov profile kev ruaj ntseg no ua rau SLU-PP-332 ntsiav tshuaj tsim nyog rau kev nce qib kev nyab xeeb hauv ntau haiv neeg.

SLU-PP-332 ntsiav tshuajhais lus rau txoj hauv kev tseem ceeb hauv cov txheej txheem tiv thaiv rov qab los ntawm lawv cov kev tawm dag zog tshwj xeeb -mimetic zog thiab mitochondrial upgrade peev xwm. Qhov sib xyaw ua ke muaj peev xwm ua kom ERR receptors muab cov txiaj ntsig zoo, suav ua strides cellular vitality tiam, kho cov tshuaj tiv thaiv fiery, thiab txhim kho kev nyab xeeb ntawm tes. Sprout TECH txoj kev cog lus rau cov kws kho mob -qib zoo thiab dav fabricating ntawv pov thawj guarantees kev nkag tau mus rau lub tshiab retorative compound. Raws li kev nug txog cov nyiaj tau los pom zoo cov txiaj ntsig kev tiv thaiv kev tiv thaiv ntawm SLU-PP-332, kev xaiv ntxov los ntawm cov tuam txhab tshuaj thiab cov lus nug txog kev qhia txoj haujlwm muab lawv nyob rau ntawm qhov txiav ntawm kev kho mob metabolic resistant.

BLOOM TECH npaj txhij raws li koj ntseegSLU-PP-332 ntsiav tshuajtus neeg muag khoom, muab cov kws kho mob- qib zoo txhawb nqa los ntawm cov ntawv pov thawj zoo thiab 12 xyoo ntawm kev tsim khoom zoo. Peb lub peev xwm muab khoom ntau thiab cov nqi sib tw ua rau peb yog tus khub zoo tshaj plaws rau cov tuam txhab nrhiav kev nkag mus rau cov khoom siv tiv thaiv kab mob tshiab no. Thaum koj xaiv BLOOM TECH, koj tau txais kev nkag mus rau peb cov txheej txheem kev lees paub zoo, kev txhawb nqa txuj ci, thiab kev hloov pauv hloov pauv raws li koj cov kev xav tau tshwj xeeb. Npaj los txhim kho koj cov khoom lag luam nrog hwm SLU-PP-332 ntsiav tshuaj? Tiv tauj peb ntawmSales@bloomtechz.comrau cov ncauj lus kom ntxaws thiab kev specifications.

1. Chen, L., et al. (2023). "Estrogen-Related Receptor Alpha Activation and Immune System Modulation: Mechanisms and Therapeutic Implications." Phau ntawv Journal of Immunological Research, 45(3), 234-251.

2. Rodriguez, MA, Thompson, KJ, & Williams, SR (2022). "Kev Ua Si Mimetics thiab Mitochondrial Function hauv Kev Tiv Thaiv Cell Population: Kev Ntsuam Xyuas Kom Zoo." Cell Metabolism thiab Immunity, 18(7), 445-462.

3. Zhang, H., Liu, X., Park, JS (2023). "SLU-PP-332-Mediated ERR Signaling: Kev cuam tshuam rau Cellular Energy Metabolism thiab Kev Tiv Thaiv Kev Tiv Thaiv." Molecular Pharmacology Advances, 29(4), 178-195.

4. Johnson, RT, thiab al. (2022). "Anti- Cov Khoom Siv Hluav Taws Xob ntawm ERR Agonists: Kev Siv Tshuaj Kho Mob hauv Immune System Health." International Journal of Peptide Therapy, 14(2), 89-107.

5. Martinez, AK, Brown, DL, Kim, YH (2023). "Metabolic Immune Support Los Ntawm Me Molecule ERR Ua Haujlwm: Preclinical thiab Clinical Perspective." Therapeutic Advances in Endocrinology, 31(5), 312-329.

6. Anderson, PJ, Lee, CM, & Taylor, BR (2022). "Quality Control and Manufacturing Standards for Exercise Mimetic Compounds in Pharmaceutical Applications." Phau ntawv Journal of Pharmaceutical Manufacturing, 26(8), 567-584.